13th European AIDS Conference/EACS, Belgrade, October 2011
Oral presentations
1 Non-AIDS defining malignancies (NADM) in the D:A:D study: Time trends and predictors of survival. S Worm for the D:A:D study group. presentation
2 Chronic hepatitis C (HCV) infection and chronic kidney disease (CKD) in HIV-infected patients in the EuroSIDA study. L Peters on behalf of the EuroSIDA study. presentation
3 The incidence of serious non-AIDS defining infections in the EuroSIDA cohort. J Reekie on behalf of the EuroSIDA study. presentation
4 Predictors of hepatitis C viremia in co-infected individuals. D Grint, A Phillips on behalf of the EuroSIDA study. presentation
5 Hepatitis delta in HIV-infected individuals in Europe. V Soriano on behalf of the EuroSIDA study.presentation
6 HIV Indicator Diseases across Europe Study (HIDES I): Results from the pilot phase.
7 Mortality Rate, TB Recurrence and Causes of Death in HIV/TB Coinfected Patients: Results from the HIV/TB Collaborative Study. DN Podlekareva, D Grint, A Panteleev, A Rakhmanova, R Miller, M Bruyand, H Furrer, F Post, I Zeltina, A Skrahin, JM Miro, N Obel, E Girardi, MH Losso, J Toibaro, J Caylá, JD Lundgren, O Kirk, HIV/TB Collaboration Study Group.
Presentation
ICAAC, September 2011
Poster presentations
1 Renal Failure Related to Broad-spectrum Antibiotics in Critically Ill Patient
ME Johansen, JU Jensen, , L Hein, B Lundgren, M Bestle, T Mohr, MH Andersen, KJ Thornberg, J Loken, M Steensen, Z Fox, H Tousi, P Soe-Jensen, AO Lauritsen, D Strange6, N Reiter, K Thormar, P Fjeldborg, KM Larsen, NE Drenck, L Ryom, C Ostergaard, J Kjaer, J Grarup, JD Lundgren. poster (82 kb)
2 Candida Infections Related to Broad-spectrum Antibiotics in Critically Ill Patients
JU Jensen, K Reinholdt, L Hein6, B Lundgren, M Bestle, T Mohr, MH Andersen, J Loken, H Tousi, P Soe-Jensen, AO Lauritsen, D Strange, N Reiter, K Thormar,
KM Larsen, NE Drenck, ME Johansen, C Ostergaard, JK Møller, B Olesen, MC Arendrup, J Kjaer, J Grarup, JD Lundgren for the PASS study group. poster (118 kb)
3 Cytomegalovirus and the Drugs Used to Prevent and Treat This Infection as Risk Factors for Longer Term Deterioration of Kidney Function after Solid Organ and Human Stem Cell Transplanantion
C da Cunha-Bang, S S Sørensen, M Iversen, H Sengeløv, A Rasmussen, F Gustafsson, Z Fox, J D Lundgren. poster (158 kb)
13th Int. Workshop on Adverse Drug Reactions and Co-morbidities in HIV, Rome, July 2011
Oral presentations
Development of a definition for Rapid Progression (RP) of renal disease in HIV-positive persons. L Ryom, DA Kamara, SW Worm, MJ Ross, P Reiss, CA Fux, P Morlat, O Moranne, O Kirk, C Smith and JD Lundgren for the D:A:D study group. presentation
Int. Workshop on HIV & Hepatitis Virus Drug Resistance & Curative Strategies, June 2011, Los Cabos
Poster presentation
1 Development of a cross European virtual sample repository and HIV resistance database. J Kjær, DK Kristensen, G Beheydt, S Imbrechts, M Rickenbach, I Fanti, F Incardona and A-M Vandamme
9th European Workshop on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, March 2011, Cyprus
Poster presentation
1 A semi-automated system to query distributed heterogeneous viral databases. G Beheydt, E Schülter, S Imbrechts, A Abecasis, FM Codoñer, D Paraskevis, A Sönnerborg, A-M Vandamme and J Kjær.
18th Conference on Retroviruses and Opportunistic Infections, Boston, February 2011
Poster Presentations
1 Risk of Cause-specific Deaths over Calendar Time and according to Cumulative Exposure to Combination Antiretroviral Therapy (cART). JD Kowalska, A Mocroft, J Reekie, A Phillips, P Reiss, B Ledergerber, J Gatell, A d'Arminio Monforte, JD Lundgren and O Kirk for the EuroSIDA study group. poster (448 KB)
2 Predictors of Virologic Response to Etravirine-based cART Regimens in a Large European Cohort of HIV-infected Patients. A Cozzi-Lepri, R Paredes, A Phillips, J Kjær, A Lazzarin, J van Lunzen, A Karlsson, M Johnson, and J Lundgren for the EuroSIDA study group. poster (141 KB)
3 Kinetics of Platelet Counts following Interruption of ART: Results from the SMART Study. E Zetterberg, J Neuhaus, for SMART/INSIGHT Study Group.
4 HCV Treatment and CD4 Cell Count Decline in HIV/HCV Co-infected Patients: European Cohort Collaboration. C Smit, A d'Arminio, F de Wolf, M Puoti, F Dabis on behalf of the HCV working group of COHERE. poster (99 KB)